Skip to main content

Enovis CORP

corporate_fare Company Profile

Enovis CORP

ENOV·NYSE·Industrial Applications And Services·CIK 0001420800

Enovis Corporation is a medical technology company that develops, manufactures, and distributes clinically differentiated solutions designed to improve patient outcomes and transform workflows. The company provides high-quality medical devices across a broad range of products used for reconstructive surgery, rehabilitation, pain management, and physical therapy. Enovis's products address the entire patient care continuum, from injury prevention to rehabilitation following surgery, injury, or degenerative disease, helping individuals regain or maintain natural motion. The company utilizes its Enovis Growth Excellence (EGX) business system, which is a set of tools, processes, and culture, to continuously improve patient outcomes and drive growth. During the year ended December 31, 2025, Enovis completed four acquisitions within its Reconstructive segment and three acquisitions within its Prevention & Recovery segment. These small acquisitions added complementary prevention & recovery product offerings, expanded distribution partners for the company's surgical implant products in Europe, and introduced a complementary surgical product technology. EGX is integral to Enovis's operations, incorporating its values and driving behaviors through comprehensive tools and repeatable processes used for continuous improvement and value creation.

Enovis CORP (NYSE:ENOV) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 16 items for ENOV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for ENOV spans 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • Enovis Jumps 12% as Q3 Profit Swing and Guidance Raise Beat Estimates
  • Enovis 10-Q: Q3 Net Income $3.4M, $170.5M Nine-Month Operating Cash Flow, No Goodwill Impairment
  • Enovis Q3 Sales $559M, Raises Adjusted EBITDA/EPS Guidance, Adds $200M Buyback
  • Enovis Lifts Full-Year EBITDA and EPS Outlook, Doubles Buyback to $200M
  • Enovis to Acquire eCential Robotics for €155M Enterprise Value, Adding Surgical Robotics to ASTRA Platform

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.25B
Net Income
-$1.18B
Diluted EPS
-$20.75
Op. Cash Flow
$217.29M
Free Cash Flow
$19.92M
Gross Profit
$1.35B
Operating Income
-$1.12B
Cash & Equivalents
$36.39M
Total Debt
$1.3B
Debt / Equity
0.87×
Net Margin
-52.7%
Shares Outstanding
57.19M sh
Source: 10-K · filed 2026-02-26 · accession 0001420800-26-000012

Short Interest & Short Volume

7.26 days to cover

FINRA reported short interest of 10,558,756 shares in ENOV as of the October 30, 2026 settlement, a 9.8% decrease from the prior period — about 7.3 days to cover at its recent average daily volume. On November 20, 2026, 52.3% of ENOV volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)10,558,756 shares as of October 30, 2026
Change vs prior period▼ 9.8%
Days to cover7.26 at avg daily volume of 1,453,809
Daily short volume (FINRA facilities)52.3% of 478,821 shares on November 20, 2026
5-day average short volume59.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with E →
$25.47
52-week range · as of 2026-11-05 $16.7 – $32.41
Market cap
$1.47B
Volume
1.2M (0.8× avg)
3-mo avg 1.6M
Live data · 2026-11-22 12:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ENOV - Latest Insights

ENOV
Nov 05, 2026, 12:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $27.64
Real-time Price: $25.47 info
Change: -$2.17 (-8%) info
Market Cap: $1.469B info
ENOV
Nov 05, 2026, 6:22 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $25.47 info
Change: -$0.300 (-1%) info
Market Cap: $1.469B info
ENOV
Nov 05, 2026, 6:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $25.47 info
Change: -$0.300 (-1%) info
Market Cap: $1.469B info
ENOV
Nov 05, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $24.35
Real-time Price: $25.47 info
Change: +$1.12 (+5%) info
Market Cap: $1.469B info
ENOV
Sep 01, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.59
Real-time Price: $25.47 info
Change: +$0.880 (+4%) info
Market Cap: $1.469B info
ENOV
Sep 01, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $24.59
Real-time Price: $25.47 info
Change: +$0.880 (+4%) info
Market Cap: $1.469B info
ENOV
Aug 06, 2026, 6:45 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $30.18
Real-time Price: $25.47 info
Change: -$4.71 (-16%) info
Market Cap: $1.469B info
ENOV
Aug 06, 2026, 6:19 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.18
Real-time Price: $25.47 info
Change: -$4.71 (-16%) info
Market Cap: $1.469B info
ENOV
Aug 06, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $30.18
Real-time Price: $25.47 info
Change: -$4.71 (-16%) info
Market Cap: $1.469B info
ENOV
May 19, 2026, 4:54 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.76
Real-time Price: $25.47 info
Change: -$0.290 (-1%) info
Market Cap: $1.469B info
ENOV
May 07, 2026, 6:33 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $25.45
Real-time Price: $25.47 info
Change: +$0.020 (+0.08%) info
Market Cap: $1.469B info
ENOV
May 07, 2026, 6:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.45
Real-time Price: $25.47 info
Change: +$0.020 (+0.08%) info
Market Cap: $1.469B info
ENOV
May 07, 2026, 6:01 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $25.45
Real-time Price: $25.47 info
Change: +$0.020 (+0.08%) info
Market Cap: $1.469B info
ENOV
Apr 06, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $22.76
Real-time Price: $25.47 info
Change: +$2.71 (+12%) info
Market Cap: $1.469B info
ENOV
Feb 26, 2026, 6:22 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $22.32
Real-time Price: $25.47 info
Change: +$3.15 (+14%) info
Market Cap: $1.469B info
ENOV
Jan 12, 2026, 6:45 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.68
Real-time Price: $25.47 info
Change: -$4.21 (-14%) info
Market Cap: $1.469B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets